Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02359305 · ClinicalTrials.gov registry record
Institutional Audit of the Use of Intravenous Acetaminophen in Infants Undergoing Pyloromyotomy
A clinical trial of Pyloric Stenosis, sponsored by Arlyne Thung.
- Completed
- Registry status
- 68
- Enrollment target
- 1
- Study location
NCT02359305: Completed study of Pyloric Stenosis, sponsored by Arlyne Thung.
NCT02359305 is a study of Pyloric Stenosis that has completed, run by Arlyne Thung. The registered enrollment target is 68 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02359305, a study of Pyloric Stenosis, has completed, sponsored by Arlyne Thung.
- COMPLETED
- Registry status
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a retrospective chart review. The objective of the current study is to determine the analgesic efficacy and side effect profile of intravenous acetaminophen when administered to infants undergoing pyloromyotomy. In addition, recovery characteristics of infants who were administered intravenous acetaminophen will be compared to infants who did not receive intravenous acetaminophen to determine if there were any appreciable differences with regard to postoperative discomfort, PACU time, time to oral feeds and hospital discharge.
Primary Outcome
One time in the OR prior to the start of surgery
Conditions Studied
Interventions
- DRUG Acetaminophen
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2014-06 |
| Est. Completion | 2016-08 |
What the finished NCT02359305 record still lists
NCT02359305 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target.
The record links to 1 condition, with Pyloric Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Acetaminophen is the first listed.
NCT02359305 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02359305 about?
NCT02359305 is a clinical study titled "Institutional Audit of the Use of Intravenous Acetaminophen in Infants Undergoing Pyloromyotomy". This is a retrospective chart review. The objective of the current study is to determine the analgesic efficacy and side effect profile of intravenous acetaminophen when administered to infants undergoing pyloromyotomy. In addition, recovery characteristics of infants who were administered intraveno...
What is the current status of trial NCT02359305?
This trial is currently completed. The enrollment target is 68 participants. The study started on 2014-06. Estimated completion is 2016-08.
What conditions does trial NCT02359305 study?
This clinical trial studies the following conditions: Pyloric Stenosis.
What interventions are being tested in trial NCT02359305?
The interventions under investigation include: Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT02359305?
This trial is sponsored by Arlyne Thung, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02359305 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pyloric Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia